The weight loss achieved by CagriSema (-20.4% at 68 weeks) is comparable to that reported with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (-20.9% with the 15-mg dose at 72 weeks in SURMOUNT-1) [14]
Not one person ever walked up to me and said, "Girl, you look like you're getting too big." But as soon as I lost weight, people were like, "Oh my God, don't lose any more." Well, you'd never tell me to raw-dog my heart condition, or my pancreas, and not take insulin
Application : Injection Sites : Common sites for SC injections include the abdomen (avoiding a 2-inch radius around the navel), the outer area of the upper arm, and the thigh
Lin SL, Chiang WC, Chen YM, Lai CF, Tsai TJ, Hsieh BS
Products are no longer confined to a single function
Made with natural ingredients to soothe and balance your gut, its the perfect companion for anyone using GLP-1 medications or looking to feel their best every day